Stock Detail
CHINA NORTH EAST PETROLEUM HOLDINGS LIMITED
Banking
NEP @ Yahoo Finance | NEP Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $2.69 | $2.84 | $-0.04 | -1.47% | 0.00 | $2.73 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $2.75 | $2.67 | 166,817 | 95.72M | 221,074.5 | 2.43 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 2.90 | 2.79 | 2.73 | 2.62 | 2.56 |
Stock Profile
Nephros, Inc. develops hemodiafiltration (HDF) products and technologies for treating patients with End Stage Renal Disease (ESRD). Its products include the company's proprietary Mid-Dilution Diafiltration technology, a fluid management system that removes renal toxins across the molecular spectrum. The company has three products in various stages of development, including OLpur MD190, a dialyzer designed for HDF therapy; the OLpur H2H, an add-on module designed to allow the most common types of hemodialysis machines to be used for HDF therapy; and the OLpur NS2000 system, a stand-alone hemodiafiltration machine and associated filter technology. Nephros sells OLpur MD190 dialyzer in some or all of Cyprus, France, Germany, Greece, Ireland, Italy, the Netherlands, Portugal, Spain, Sweden, Switzerland, and the United Kingdom. The company was founded in 1997 and is based in New York City.